PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 12:01 AM ET

Sponsor Check › Person

Robert Weisskoff

Related person on Form D filings · address states as listed: MA, NJ, MN, OH, CA · listed Mar 24, 2015 → Oct 19, 2026

18issuers
56Form D filings
2015–2026years listed

Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 23, 2026, 11:56 PM ET · SEC enforcement last checked: not yet

Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.

Key records

The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.

1. Lawsuits

None found in sources searched.

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.

Not yet searched.

Search queued. Results are added automatically; check back later or follow this page to be notified.

3. Bankruptcies

None found in sources searched.

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:56 PM ET.

State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons are made for sponsors and sponsor groups, not individual people.

5. Money to insiders and sales commissions

2 of 49 offerings report sales commissions totalling $8,726,979; 0 report finder's fees; 4 report proceeds to related persons totalling $1,508,000. (includes amounts the issuer reported as estimates)

SourceOffering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell it
EDGAR ↗Oct 19, 2026 D
File 021-601738
$0$0$0None listed on this filing
EDGAR ↗Apr 23, 2026 D
File 021-581637
$0$0$0None listed on this filing
EDGAR ↗Oct 14, 2025 D
File 021-560739
$0$0$0None listed on this filing
EDGAR ↗Jul 8, 2025 D
File 021-550950
$0$0$0None listed on this filing
EDGAR ↗Nov 19, 2024 D
File 021-529812
$0$0$0None listed on this filing
EDGAR ↗Jul 29, 2024 D/A
File 021-489534
$0$0$0None listed on this filing
EDGAR ↗Feb 14, 2024 D
File 021-505327
$0$0$0None listed on this filing
EDGAR ↗Feb 14, 2024 D
File 021-505329
$0$0$0None listed on this filing
EDGAR ↗Jan 10, 2022 D
File 021-428629
$0$0$0None listed on this filing
EDGAR ↗Oct 21, 2021 D
File 021-417842
$0$0$0None listed on this filing
EDGAR ↗Oct 21, 2021 D
File 021-417848
$0$0$0None listed on this filing
EDGAR ↗Oct 21, 2021 D
File 021-417860
$3,087,000$0$0SVB Leerink LLC BrokerCheck CRD 39011 ↗
EDGAR ↗Oct 21, 2021 D
File 021-417877
$0$0$0None listed on this filing
EDGAR ↗May 20, 2021 D/A
File 021-396049
$0$0$0None listed on this filing
EDGAR ↗May 6, 2021 D
File 021-398517
$0$0$0None listed on this filing
EDGAR ↗Mar 5, 2021 D
File 021-391380
$5,639,979$0$0SVB Leerink LLC BrokerCheck CRD 39011 ↗
EDGAR ↗Jan 21, 2021 D
File 021-387002
$0$0$0None listed on this filing
EDGAR ↗Jun 18, 2020 D
File 021-369265
$0$0$0None listed on this filing
EDGAR ↗Apr 24, 2020 D
File 021-365710
$0$0$0None listed on this filing
EDGAR ↗Mar 27, 2020 D
File 021-363863
$0$0$0None listed on this filing
EDGAR ↗Feb 12, 2020 D/A
File 021-306741
$0$0$0None listed on this filing
EDGAR ↗Jan 28, 2020 D/A
File 021-347004
$0$0$0None listed on this filing
EDGAR ↗Aug 13, 2018 D
File 021-319020
$0$0$0None listed on this filing
EDGAR ↗Dec 27, 2017 D/A
File 021-296213
$0$0$0None listed on this filing
EDGAR ↗Jul 11, 2017 D
File 021-290358
$0$0$0None listed on this filing
EDGAR ↗May 25, 2016 D
File 021-263801
$0$0$0None listed on this filing
EDGAR ↗Mar 3, 2016 D
File 021-258524
$0$0$0None listed on this filing
EDGAR ↗Jul 15, 2015 D/A
File 021-197489
$0$0$768,000
A portion of the proceeds will be used to pay the salaries of the executive officers in the ordinary course of business.
None listed on this filing
EDGAR ↗Mar 24, 2015 D/A
File 021-225136
$0$0$0None listed on this filing
EDGAR ↗Mar 4, 2015 D
File 021-235161
$0$0$0None listed on this filing
EDGAR ↗Jan 8, 2015 D
File 021-231795
$0$0$0None listed on this filing
EDGAR ↗Dec 3, 2013 D
File 021-207317
$0$0$0None listed on this filing
EDGAR ↗Sep 25, 2013 D
File 021-203529
$0$0$400,000 (est.)None listed on this filing
EDGAR ↗May 17, 2013 D
File 021-196697
$0$0$0None listed on this filing
EDGAR ↗Feb 21, 2013 D/A
File 021-188257
$0$0$0None listed on this filing
EDGAR ↗Dec 5, 2012 D
File 021-187890
$0$0$215,000 (est.)None listed on this filing
EDGAR ↗Mar 15, 2012 D
File 021-174983
$0 (est.)$0 (est.)$0 (est.)None listed on this filing
EDGAR ↗Jan 13, 2012 D
File 021-171774
$0$0$125,000 (est.)None listed on this filing
EDGAR ↗Aug 26, 2011 D/A
File 021-161755
$0$0$0 (est.)None listed on this filing
EDGAR ↗Sep 28, 2010 D
File 021-148242
$0$0$0None listed on this filing
EDGAR ↗Jul 26, 2010 D
File 021-145470
$0$0$0None listed on this filing
EDGAR ↗Jul 9, 2010 D
File 021-144654
$0$0$0 (est.)None listed on this filing
EDGAR ↗Jun 25, 2010 D
File 021-144039
$0$0$0None listed on this filing
EDGAR ↗Jun 9, 2010 D
File 021-143220
$0$0$0None listed on this filing
EDGAR ↗May 28, 2010 D
File 021-142724
$0$0$0None listed on this filing
EDGAR ↗Dec 9, 2009 D
File 021-101585
$0$0$0None listed on this filing
EDGAR ↗Nov 3, 2009 D
File 021-50801
$0$0$0None listed on this filing
EDGAR ↗Sep 23, 2009 D
File 021-94056
$0$0$0None listed on this filing
EDGAR ↗Jul 14, 2009 D
File 021-102715
$0$0$0 (est.)None listed on this filing

As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Appears on these filings

SourceIssuerRoleFiledFormOfferingSoldInvestorsMin. investment
EDGAR ↗Adela, Inc.DirectorOct 19, 2026D$12,000,000
similar: $2,000,000–$19,999,994
$12,000,0005
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Adela, Inc.DirectorApr 23, 2026D$5,000,000
similar: $2,000,000–$19,999,994
$5,000,0001
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Affinia Therapeutics Inc.DirectorOct 14, 2025D$45,000,000
similar: $500,000–$7,000,000
$13,268,33520
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Adela, Inc.DirectorJul 8, 2025D$27,000,000
similar: $2,000,000–$19,999,994
$25,425,4429
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Zenflow, Inc.DirectorNov 19, 2024D$25,203,352
similar: $829,831–$9,999,998
$19,422,85536
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Adela, Inc.DirectorJul 29, 2024D/A$49,317,173
similar: $2,000,000–$19,999,994
$48,540,78011
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Adela, Inc.DirectorFeb 14, 2024D$3,296,554
similar: $2,000,000–$19,999,994
$3,296,5543
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Adela, Inc.DirectorFeb 14, 2024D$1,187,700
similar: $2,000,000–$19,999,994
$1,187,7002
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Adela, Inc.DirectorAug 11, 2023D$29,199,991
similar: $2,000,000–$19,999,994
$28,031,9938
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ShouTi Inc.DirectorJan 10, 2022D$6,999,917
similar: $2,000,000–$19,999,994
$6,999,9178
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ShouTi Inc.DirectorOct 21, 2021D$100,000,022
similar: $2,000,000–$19,999,994
$100,000,02230
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ShouTi Inc.DirectorOct 21, 2021D$32,000,640
similar: $2,000,000–$19,999,994
$32,000,6406
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Basecamp Bio Inc.DirectorOct 21, 2021D$14,000,000
similar: $2,000,000–$19,999,994
$9,000,0009
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ShouTi Inc.DirectorOct 21, 2021D$25,999,992
similar: $2,000,000–$19,999,994
$25,999,9929
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Zenflow, Inc.DirectorMay 20, 2021D/A$24,368,845
similar: $829,831–$9,999,998
$24,368,84543
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Affinia Therapeutics Inc.DirectorMay 6, 2021D$109,999,955
similar: $500,000–$7,000,000
$109,999,95522
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Zenflow, Inc.DirectorApr 15, 2021D$23,699,998
similar: $829,831–$9,999,998
$23,699,99840
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Caribou Biosciences, Inc.DirectorMar 5, 2021D$114,999,613
similar: $2,000,000–$19,999,994
$114,999,61336
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Xilio Therapeutics, Inc.DirectorJan 21, 2021D$50,249,990
similar: $2,000,000–$19,999,994
$50,249,99016
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Checkmate Pharmaceuticals, Inc.DirectorJun 18, 2020D$100,083,274
similar: $2,000,000–$19,999,994
$85,083,28017
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Checkmate Pharmaceuticals, Inc.DirectorApr 24, 2020D$10,000,000
similar: $2,000,000–$19,999,994
$10,000,0004
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Affinia Therapeutics Inc.DirectorMar 27, 2020D$68,522,920
similar: $500,000–$7,000,000
$38,522,94216
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗Tempest Therapeutics, Inc.
group: Longwood
DirectorFeb 12, 2020D/A$100,186,733
similar: $829,831–$9,999,998
$83,186,73310
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Checkmate Pharmaceuticals, Inc.DirectorJan 28, 2020D/A$15,999,999
similar: $2,000,000–$19,999,994
$15,999,9994
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Tempest Therapeutics, Inc.
group: Longwood
DirectorFeb 27, 2019D/A$70,186,738
similar: $829,831–$9,999,998
$48,186,7388
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Farapulse, Inc.DirectorAug 13, 2018D$12,000,000
similar: $2,000,000–$19,999,994
$11,999,99332
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Tempest Therapeutics, Inc.
group: Longwood
DirectorMar 1, 2018D$70,186,738
similar: $829,831–$9,999,998
$25,186,7388
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Zenflow, Inc.DirectorDec 27, 2017D/A$32,224,519
similar: $829,831–$9,999,998
$31,494,74686
similar: 2–15
$1
similar: $10,000–$54,310
EDGAR ↗Farapulse, Inc.DirectorJul 11, 2017D$5,000,000
similar: $2,000,000–$19,999,994
$5,000,0002
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Caribou Biosciences, Inc.DirectorMay 25, 2016D$30,070,244
similar: $2,000,000–$19,999,994
$14,459,30611
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Farapulse, Inc.DirectorMar 3, 2016D$23,999,173
similar: $2,000,000–$19,999,994
$14,999,17335
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗Amphora Medical, Inc.DirectorJul 15, 2015D/A$12,782,106
similar: $829,831–$9,999,998
$12,782,1068
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗Caribou Biosciences, Inc.DirectorMar 24, 2015D/A$11,549,904
similar: $2,000,000–$19,999,994
$11,549,90414
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorMar 4, 2015D$15,000,000
similar: $1,100,015–$10,001,163
$15,000,0001
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorJan 8, 2015D$16,800,000
similar: $1,100,015–$10,001,163
$16,273,38510
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorDec 3, 2013D$14,999,993
similar: $1,100,015–$10,001,163
$14,999,9938
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗BIOCONNECT SYSTEMS INCDirectorSep 25, 2013D$12,500,000
similar: $2,000,000–$19,999,994
$9,069,9227
similar: 2–16
$25,000
similar: $10,000–$50,000
EDGAR ↗Amphora Medical, Inc.DirectorJun 5, 2013D$1,250,000
similar: $829,831–$9,999,998
$600,0004
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorMay 17, 2013D$17,432,178
similar: $1,100,015–$10,001,163
$14,999,9987
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorFeb 21, 2013D/A$12,153,073
similar: $1,100,015–$10,001,163
$10,872,3547
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorDec 12, 2012D$6,660,099
similar: $1,100,015–$10,001,163
$5,872,3557
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗BIOCONNECT SYSTEMS INCDirectorDec 5, 2012D$1,600,000
similar: $2,000,000–$19,999,994
$1,485,7946
similar: 2–16
$4,504
similar: $10,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorMar 15, 2012D$26,305,075
similar: $1,100,015–$10,001,163
$26,305,07518
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗BIOCONNECT SYSTEMS INCDirectorJan 13, 2012D$938,392
similar: $2,000,000–$19,999,994
$469,1966
similar: 2–16
$1,407
similar: $10,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorAug 26, 2011D/A$10,350,000
similar: $1,100,015–$10,001,163
$10,336,59915
similar: 2–14
$1,280
similar: $5,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorJun 23, 2011D$10,223,950
similar: $1,100,015–$10,001,163
$10,000,0008
similar: 2–14
$1,280
similar: $5,000–$50,000
EDGAR ↗TRANSAVE INCDirectorSep 28, 2010D$6,000,000
similar: $2,000,000–$19,999,994
$2,000,0000
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗VIEWRAY INC
group: Viewray
DirectorJul 26, 2010D$19,998,591
similar: $1,100,015–$10,001,163
$19,998,5918
similar: 2–14
$23,000
similar: $5,000–$50,000
EDGAR ↗ACCURI CYTOMETERS INCDirectorJul 9, 2010D$6,000,000
similar: $829,831–$9,999,998
$6,000,00027
similar: 2–15
No minimum reported
similar: $10,000–$54,310
EDGAR ↗TRANSAVE INCDirectorJun 25, 2010D$5,855,619
similar: $2,000,000–$19,999,994
$5,499,9990
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗ACORN CARDIOVASCULAR INCDirectorJun 9, 2010D$500,000
similar: $1,100,015–$10,001,163
$478,47612
similar: 2–14
No minimum reported
similar: $5,000–$50,000
EDGAR ↗TETRAPHASE PHARMACEUTICALS INC
group: Tetraphase
DirectorMay 28, 2010D$45,000,000
similar: $1,694,259–$16,000,000
$44,750,00014
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗Ikano Therapeutics Inc.DirectorDec 9, 2009DIndefinite
similar: $1,694,259–$16,000,000
$892,71914
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗TRANSAVE INCDirectorNov 3, 2009D$12,000,000
similar: $2,000,000–$19,999,994
$5,542,5730
similar: 2–16
No minimum reported
similar: $10,000–$50,000
EDGAR ↗TETRAPHASE PHARMACEUTICALS INC
group: Tetraphase
DirectorSep 23, 2009D$29,627,203
similar: $1,694,259–$16,000,000
$10,000,0009
similar: 1–13
No minimum reported
similar: $10,000–$55,000
EDGAR ↗ACCURI CYTOMETERS INCDirectorJul 14, 2009D$4,000,000
similar: $829,831–$9,999,998
$3,749,97122
similar: 2–15
No minimum reported
similar: $10,000–$54,310

Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.

"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

Other listings under the same name

Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.

Connections as of Oct 23, 2026, 5:45 PM ET

Listed alongside — 40 names on the same filings (0 management entities, 40 people)

People and management entities the issuers listed as related persons on the same Form D filings as Robert Weisskoff. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.

  • David P. Bonita — 17 shared filings (2 issuers) · role as listed: Director · also listed on 26 other issuers
  • Caley Castelein — 10 shared filings (1 issuer) · role as listed: Director · also listed on 6 other issuers
  • James F. Dempsey — 10 shared filings (1 issuer) · roles as listed: Director, Executive Officer, Promoter · also listed on 1 other issuer
  • Joshua Bilenker — 10 shared filings (1 issuer) · role as listed: Director · also listed on 3 other issuers
  • Mark Gold — 10 shared filings (1 issuer) · role as listed: Director · also listed on 7 other issuers
  • David Chandler — 9 shared filings (1 issuer) · role as listed: Executive Officer · also listed on 1 other issuer
  • Peter Roemer — 8 shared filings (1 issuer) · role as listed: Director
  • David Scheer — 7 shared filings (1 issuer) · roles as listed: Executive Officer, Director, Promoter · also listed on 3 other issuers
  • Paul Brown — 7 shared filings (1 issuer) · role as listed: Director · also listed on 2 other issuers
  • Maneesh Jain — 7 shared filings (1 issuer) · roles as listed: Director, Promoter · also listed on 1 other issuer
  • Daniel Diniz De Carvalho — 7 shared filings (1 issuer) · roles as listed: Executive Officer, Promoter
  • Anne-Renee Hartman — 7 shared filings (1 issuer) · role as listed: Executive Officer
  • Alan Williams — 7 shared filings (1 issuer) · role as listed: Executive Officer
  • Gregory M. Ayers — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director, Promoter
  • Lisa Alderson — 6 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Andrew ElBardissi — 6 shared filings (2 issuers) · role as listed: Director · also listed on 10 other issuers
  • Raymond Stevens — 5 shared filings (2 issuers) · role as listed: Director · also listed on 1 other issuer
  • Chris A. Raanes — 5 shared filings (1 issuer) · roles as listed: Executive Officer, Director · also listed on 1 other issuer
  • Priscilla Huang — 5 shared filings (1 issuer) · role as listed: Executive Officer
  • David Grayzel — 4 shared filings (2 issuers) · role as listed: Director · also listed on 13 other issuers
  • Jay Andrew — 4 shared filings (1 issuer) · role as listed: Director
  • Petpiboon Prasit — 4 shared filings (2 issuers) · role as listed: Director · also listed on 5 other issuers
  • Daniel Auerbach — 4 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Radu Cautis — 4 shared filings (1 issuer) · role as listed: Director · also listed on 4 other issuers
  • Shreya Mehta — 4 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Cuiping Gu — 4 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Jun Yoon — 4 shared filings (1 issuer) · role as listed: Director
  • BRYAN KIM — 4 shared filings (1 issuer) · role as listed: Director · also listed on 8 other issuers
  • Ramy Farid — 4 shared filings (1 issuer) · role as listed: Director
  • Jessica Lifton — 4 shared filings (1 issuer) · role as listed: Director
  • Ting Xie — 4 shared filings (1 issuer) · role as listed: Director
  • Karla Jarvis — 4 shared filings (1 issuer) · role as listed: Executive Officer
  • Chen Ming Yu — 4 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Charles Hadley — 4 shared filings (2 issuers) · role as listed: Director · also listed on 5 other issuers
  • Rick Modi — 3 shared filings (1 issuer) · roles as listed: Executive Officer, Director
  • Luc Vandenberghe — 3 shared filings (1 issuer) · role as listed: Director · also listed on 1 other issuer
  • Sean Nolan — 3 shared filings (1 issuer) · role as listed: Director
  • Alex Barkas — 3 shared filings (1 issuer) · role as listed: Director · also listed on 3 other issuers
  • Corey Goodman — 3 shared filings (1 issuer) · role as listed: Director · also listed on 20 other issuers
  • Richard S. Kollender — 3 shared filings (1 issuer) · role as listed: Director · also listed on 6 other issuers

Other offering types (Regulation A and Regulation Crowdfunding)

None found in sources searched.

Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.

Export this report as PDF (members · included free during the launch period)

Change history

No corrections have been requested for this page.

Facts from public records only, each linked to its source. No ratings, no opinions. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Robert Weisskoff appears on a new Form D, or when a court case or SEC action is matched to them. See plans →